Withaferin A protects against hyperuricemia induced kidney injury and its possible mechanisms

References

• Haidari F, Rashidi MR, Keshavarz SA, et al. Effects of onion on serum uric acid levels and hepatic xanthine dehydrogenase/xanthine oxidase activities in hyperuricemic rats. Pak J Biol Sci. 2008;11(14):1779–1784.
   PubMedGoogle Scholar
• Chen JH, Chuang SY, Chen HJ, et al. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009;61(2):225–232.
   PubMed Web of Science ®Google Scholar
• Bjornstad P, Laffel L, Lynch J, et al., TS Group. Elevated serum uric acid is associated with greater risk for hypertension and diabetic kidney diseases in obese adolescents with Type 2 Diabetes: an observational analysis from the treatment options for type 2 diabetes in adolescents and youth (TODAY) study. Diabetes Care. 2019;42(6):1120–1128. .
   PubMed Web of Science ®Google Scholar
• Wang S, Fan J, Mei X, et al. Interleukin-22 attenuated renal tubular injury in aristolochic acid nephropathy via suppressing activation of NLRP3 inflammasome. Front Immunol. 2019;10:2277.
   PubMed Web of Science ®Google Scholar
• So A, Thorens B. Uric acid transport and disease. J Clin Invest. 2010;120(6):1791–1799.
   PubMed Web of Science ®Google Scholar
• Lu YH, Chang YP, Li T, et al. Empagliflozin attenuates hyperuricemia by upregulation of ABCG2 via AMPK/AKT/CREB signaling pathway in Type 2 diabetic mice. Int J Biol Sci. 2020;16(3):529–542.
   PubMed Web of Science ®Google Scholar
• Xu X, Li C, Zhou P, et al. Uric acid transporters hiding in the intestine. Pharm Biol. 2016;54(12):3151–3155.
   PubMed Web of Science ®Google Scholar
• Graessler J, Graessler A, Unger S, et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum. 2006;54(1):292–300.
   PubMedGoogle Scholar
• Vazquez-Mellado J, Jimenez-Vaca AL, Cuevas-Covarrubias S, et al. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford). 2007;46(2):215–219.
   PubMed Web of Science ®Google Scholar
• Umamaheswari M, Asokkumar K, Sivashanmugam AT, et al. In vitro xanthine oxidase inhibitory activity of the fractions of Erythrina stricta Roxb. J Ethnopharmacol. 2009;124(3):646–648.
   PubMed Web of Science ®Google Scholar
• Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther. 2006;8(Suppl 1):S3.
   PubMed Web of Science ®Google Scholar
• Batumalaie K, Amin MA, Murugan DD, et al. Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation. Sci Rep. 2016;6:27236.
   PubMed Web of Science ®Google Scholar
• Khalilpourfarshbafi M, Devi Murugan D, Abdul Sattar MZ, et al. Withaferin A inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice. PLoS One. 2019;14(6):e0218792.
   PubMed Web of Science ®Google Scholar
• Lee J, Liu J, Feng X, et al. Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice. Nat Med. 2016;22(9):1023–1032.
   PubMed Web of Science ®Google Scholar
• Sabina EP, Chandal S, Rasool MK. Inhibition of monosodium urate crystal-induced inflammation by withaferin A. J Pharm Pharm Sci. 2008;11(4):46–55.
   PubMed Web of Science ®Google Scholar
• Oh DR, Kim JR, Choi CY, et al. Effects of ChondroT on potassium oxonate-induced hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1. BMC Complement Altern Med. 2019;19(1):10.
   PubMed Web of Science ®Google Scholar
• Peddakkulappagari CS, Saifi MA, Khurana A, et al. Withaferin A ameliorates renal injury due to its potent effect on inflammatory signaling. Biofactors. 2019;45(5):750–762.
   PubMed Web of Science ®Google Scholar
• Sayed N, Khurana A, Saifi MA, et al. Withaferin A reverses bile duct ligation-induced liver fibrosis by modulating extracellular matrix deposition: role of LOXL2/Snail1, vimentin, and NFkappaB signaling. Biofactors. 2019;45(6):959–974.
   PubMed Web of Science ®Google Scholar
• Bale S, Venkatesh P, Sunkoju M, et al. An adaptogen: Withaferin A ameliorates in vitro and in vivo pulmonary fibrosis by modulating the interplay of fibrotic, matricellular proteins, and cytokines. Front Pharmacol. 2018;9:248.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Xiang W, Jiang Y, et al. Withaferin A alleviates traumatic brain injury induced secondary brain injury via suppressing apoptosis in endothelial cells and modulating activation in the microglia. Eur J Pharmacol. 2020;874:172988.
   PubMed Web of Science ®Google Scholar
• Chen CM, Chung YP, Liu CH, et al. Withaferin A protects against endoplasmic reticulum stress-associated apoptosis, inflammation, and fibrosis in the kidney of a mouse model of unilateral ureteral obstruction. Phytomedicine. 2020;79:9.
   Web of Science ®Google Scholar
• Su Q, Su H, Nong Z, et al. Hypouricemic and nephroprotective effects of an active fraction from polyrhachis vicina roger on potassium oxonate-induced hyperuricemia in rats. Kidney Blood Press Res. 2018;43(1):220–233.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li C, Duan S, et al. Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Biomed Pharmacother. 2019;118:109195.
   PubMed Web of Science ®Google Scholar
• Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis. Annu Rev Physiol. 2015;77:323–345.
   PubMed Web of Science ®Google Scholar
• Lipkowitz MS. Regulation of uric acid excretion by the kidney. Curr Rheumatol Rep. 2012;14(2):179–188.
   PubMed Web of Science ®Google Scholar
• Abramson RG, Levitt MF. Use of pyrazinamide to assess renal uric acid transport in the rat: a micropuncture study. Am J Physiol. 1976;230(5):1276–1283.
   PubMedGoogle Scholar
• Yun Y, Yin H, Gao Z, et al. Intestinal tract is an important organ for lowering serum uric acid in rats. PLoS One. 2017;12(12):e0190194.
   PubMed Web of Science ®Google Scholar
• Sorensen LB. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum. 1965;8(5):694–706.
   PubMedGoogle Scholar
• Zha D, Wu S, Gao P, et al. Telmisartan attenuates uric acid-induced epithelial-mesenchymal transition in renal tubular cells. Biomed Res Int. 2019;2019:3851718.
   PubMed Web of Science ®Google Scholar
• He L, Fan Y, Xiao W, et al. Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy. Oncotarget. 2017;8(67):111295–111308.
   PubMedGoogle Scholar